Distalmotion, a medical technology company empowering access to the benefits of robotic surgery in outpatient sites of care, has announced the successful closing of its Series G financing round. The $150 million financing was led by Revival Healthcare Capital and included inside investor participation.
This new funding will be used primarily to accelerate US commercial adoption of Dexter, its soft tissue robotic surgery system, as well as to support ongoing clinical and product development initiatives.
A major focus of the US expansion continues to be the Ambulatory Surgery Center (ASC) market – one of the fastest-growing segments in surgical care, driven by the ongoing shift toward efficient, outpatient surgery. [Read more…] about Distalmotion raises $150 million to accelerate US expansion of its Dexter robotic surgery system